Mirum Pharmaceuticals to Showcase LIVMARLI® (maralixibat) Data at EASL and ESPGHAN Annual Congresses
- Eight abstracts accepted, including three oral presentations - Maralixibat data highlighting predictors of event-free survival in patients with Alagille syndrome nominated for prestigious Alex... | June 13, 2022